Desmoplastic Melanoma

Desmoplastic Melanoma, explained simply

Everything a patient or caregiver wants to understand: what desmoplastic melanoma is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is desmoplastic melanoma?

Desmoplastic melanoma is an uncommon subtype of melanoma made up of spindle-shaped cells woven through dense, scar-like (fibrous) tissue. It usually appears on chronically sun-damaged skin — most often the head and neck — in older adults, and it can be easy to miss because it often lacks the dark pigment people associate with melanoma, showing up instead as a firm, flesh-colored or pink lump or a scar-like area. Two features set it apart from ordinary melanoma: it has a strong tendency to grow along nerves (perineural invasion), which can let it extend beyond what is visible, and it has a relatively low tendency to spread to lymph nodes when it is the 'pure' form. Because of the nerve-tracking habit and its location on the face, wide and complete surgical removal is essential, and radiation is used more often here than in other melanomas. Desmoplastic melanoma also tends to carry a very high number of gene mutations from sun exposure, which is thought to be one reason it can respond especially well to immunotherapy when it spreads.

In one line: Desmoplastic melanoma is an uncommon, often colorless form of melanoma that grows as a firm scar-like patch on sun-damaged skin and tends to creep along nerves — surgery is the main treatment, and unlike most melanomas it is notably responsive to radiation.

The main types

Doctors group desmoplastic melanoma by where it starts and how it behaves:

TypeWhat it means, simply
Pure desmoplastic melanomaMore than about 90% of the tumor is the scar-like desmoplastic type. It has a lower risk of spreading to lymph nodes, so a sentinel-node biopsy is often not needed.
Mixed (combined) desmoplastic melanomaContains a significant amount of ordinary melanoma alongside the desmoplastic part. It behaves more like conventional melanoma, with a higher risk of node spread, so node sampling is usually considered.

Staging, in plain terms

Desmoplastic melanoma uses the standard melanoma staging based on how deep the tumor goes (thickness), whether the skin is broken (ulceration), and whether it has reached lymph nodes or distant organs. Desmoplastic melanomas are often thick at diagnosis because they are colorless and found late, but the pure form spreads to nodes less often than its thickness would suggest.

Melanoma AJCC TNM stagingWhat it generally means
Stage I–II (localized)Tumor confined to the skin, with deeper or ulcerated tumors counting as stage II. Treated with wide surgical removal, often with radiation added for high-risk features.
Stage III (regional)Spread to nearby lymph nodes or along skin lymphatics. Managed with surgery, radiation to the area, and often immunotherapy.
Stage IV (metastatic)Spread to distant organs. Treated mainly with immunotherapy, to which desmoplastic melanoma often responds particularly well.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Desmoplastic Melanoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Wide surgical removal

The cornerstone of treatment is removing the tumor with a generous margin of healthy tissue, because the cells can extend invisibly beyond the obvious lump, especially along nerves.

Radiation after surgery

Unlike most melanomas, desmoplastic melanoma is often treated with radiation to the surgical area — particularly when margins are close, the tumor tracked along nerves, or it is on the head and neck — to lower the chance of local recurrence.

Sentinel-node biopsy (selective)

For the pure form, which rarely spreads to nodes, a sentinel-node biopsy is often skipped; for mixed tumors it is usually considered, just as in ordinary melanoma.

Immunotherapy for advanced disease

When the cancer spreads, immune-checkpoint drugs are the main treatment, and desmoplastic melanoma — with its very high mutation load — often responds especially well to them.

How radiation treatment works

Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while normal cells are better at repairing themselves. Most melanomas respond poorly to radiation, but desmoplastic melanoma is an important exception: radiation after surgery meaningfully lowers the chance of the cancer coming back, especially when the tumor was on the head and neck, had close margins, or grew along nerves. The radiation field is sometimes extended along an involved nerve's path to cover cells that surgery cannot see. It is given as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.

The main ways radiation is delivered for desmoplastic melanoma:

Surgery

Wide local excision with clear margins is the primary treatment; on the face, specialized techniques help remove the tumor completely while preserving as much healthy tissue as possible.

Adjuvant radiation

External-beam radiation to the tumor bed after surgery reduces local recurrence, which matters more here because of the tumor's nerve-tracking growth and frequent head-and-neck location.

Radiation along nerve pathways

When the tumor has invaded nerves, the radiation field can be extended along the involved nerve's path to cover microscopic disease that surgery may not reach.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

Radiation reduces local recurrence: Studies of head-and-neck desmoplastic melanoma show that adding radiation after surgery substantially lowers the chance the tumor returns locally, making it a standard consideration for higher-risk tumors — a notable difference from other melanomas.[1]

Melanoma radiation-therapy studies (2020–2025)

Strong responses to immunotherapy: Because desmoplastic melanoma carries an unusually high number of sun-related mutations, it tends to respond especially well to immune-checkpoint therapy, with high response rates reported in patients with advanced disease.[2]

Immunotherapy trials and analyses (2021–2025)

Sparing the node biopsy in pure tumors: Evidence that pure desmoplastic melanoma rarely spreads to lymph nodes supports often omitting sentinel-node biopsy for this subtype, while keeping it for mixed tumors that behave like conventional melanoma.[3]

Surgical melanoma outcome studies (2020–2024)

Common questions

Why didn't my melanoma look dark? Desmoplastic melanoma often makes little or no pigment, so instead of a dark spot it can look like a firm, flesh-colored or pink lump or a scar-like patch on sun-damaged skin. That is one reason it is easy to miss and is often found later than other melanomas.

Why am I being offered radiation when melanoma usually isn't treated that way? Desmoplastic melanoma is an exception. It tends to grow along nerves and often sits on the head and neck, so radiation after surgery is frequently used to lower the chance it comes back in the same area — even though radiation is not a routine part of treating most other melanomas.

Do I need a lymph-node biopsy? It depends on the type. The 'pure' form rarely spreads to lymph nodes, so a sentinel-node biopsy is often not needed. The 'mixed' form behaves more like ordinary melanoma, so node sampling is usually considered. Your team will base this on your pathology.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. Melanoma radiation-therapy studies (2020–2025) (no indexed identifier — see your care team)
  2. Immunotherapy trials and analyses (2021–2025) (no indexed identifier — see your care team)
  3. Surgical melanoma outcome studies (2020–2024) (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides